IT1318495B1 - Formulazioni farmaceutiche, a rilascio modificato, con elevatabiodisponibilita', contenenti principi attivi ad attivita' - Google Patents

Formulazioni farmaceutiche, a rilascio modificato, con elevatabiodisponibilita', contenenti principi attivi ad attivita'

Info

Publication number
IT1318495B1
IT1318495B1 IT2000MI000972A ITMI20000972A IT1318495B1 IT 1318495 B1 IT1318495 B1 IT 1318495B1 IT 2000MI000972 A IT2000MI000972 A IT 2000MI000972A IT MI20000972 A ITMI20000972 A IT MI20000972A IT 1318495 B1 IT1318495 B1 IT 1318495B1
Authority
IT
Italy
Prior art keywords
activities
active ingredients
pharmaceutical formulations
modified release
containing active
Prior art date
Application number
IT2000MI000972A
Other languages
English (en)
Inventor
Lauretta Maggi
Ubaldo Conte
Original Assignee
Lisapharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lisapharma Spa filed Critical Lisapharma Spa
Priority to IT2000MI000972A priority Critical patent/IT1318495B1/it
Publication of ITMI20000972A0 publication Critical patent/ITMI20000972A0/it
Priority to EP01110735A priority patent/EP1151747A1/en
Publication of ITMI20000972A1 publication Critical patent/ITMI20000972A1/it
Application granted granted Critical
Publication of IT1318495B1 publication Critical patent/IT1318495B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT2000MI000972A 2000-05-04 2000-05-04 Formulazioni farmaceutiche, a rilascio modificato, con elevatabiodisponibilita', contenenti principi attivi ad attivita' IT1318495B1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT2000MI000972A IT1318495B1 (it) 2000-05-04 2000-05-04 Formulazioni farmaceutiche, a rilascio modificato, con elevatabiodisponibilita', contenenti principi attivi ad attivita'
EP01110735A EP1151747A1 (en) 2000-05-04 2001-05-03 Modified release pharmaceutical formulations containing active principles having antibiotic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000MI000972A IT1318495B1 (it) 2000-05-04 2000-05-04 Formulazioni farmaceutiche, a rilascio modificato, con elevatabiodisponibilita', contenenti principi attivi ad attivita'

Publications (3)

Publication Number Publication Date
ITMI20000972A0 ITMI20000972A0 (it) 2000-05-04
ITMI20000972A1 ITMI20000972A1 (it) 2001-11-04
IT1318495B1 true IT1318495B1 (it) 2003-08-25

Family

ID=11444968

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000MI000972A IT1318495B1 (it) 2000-05-04 2000-05-04 Formulazioni farmaceutiche, a rilascio modificato, con elevatabiodisponibilita', contenenti principi attivi ad attivita'

Country Status (2)

Country Link
EP (1) EP1151747A1 (it)
IT (1) IT1318495B1 (it)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제

Also Published As

Publication number Publication date
ITMI20000972A0 (it) 2000-05-04
EP1151747A1 (en) 2001-11-07
ITMI20000972A1 (it) 2001-11-04

Similar Documents

Publication Publication Date Title
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
HUP0300263A3 (en) Anthranilamides derivatives, their use and arthropodicide compositions containing them as active ingredient
NO20010283D0 (no) Bioforsterkede formuleringer omfattende eprosartan i oral fast doseringsform
DE69942921D1 (de) Osmotische Dosierungsform mit verlängerter Wirkstoffabgabe
BR0212921A (pt) Composição farmacêutica com base em fondant
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
NO20026037L (no) Sötvareprodukt som inneholder aktive bestanddeler
ITTO20010005A1 (it) Formulazione farmaceutica.
MY129356A (en) Electrospun pharmaceutical compositions
ATE253896T1 (de) Zwei oder mehrere wirkstoffe enthaltende pharmazeutische aerosolformulierungen
IS6263A (is) Lyfjasamsetningar, sem innihalda trípeptíð
MXPA03000881A (es) Nuevos compuestos heterociclicos, su preparacion y su utilizacion como medicamentos, en especial como antibacterianos.
HUP0301573A3 (en) Substituted arylpyrazines, pharmaceutical compositions containing them and their use
NO20031005L (no) Pesticidale formuleringer
AU2002335046A1 (en) The use of proton sequestering agents in drug formulations
HUP0301777A3 (en) Aniline-derived ligands for the thyroid receptor, pharmaceutical compositions comprising thereof and their use
BR0112962B1 (pt) Composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
HUP0300653A3 (en) Liquid composition formulations, containing herbicidal active ingredients preparing and use thereof
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
HUP0301949A3 (en) Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
HUP0400967A3 (en) Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them
HUP0301177A3 (en) Ion-strength independent sustained release pharmaceutical formulation
HUP0302193A3 (en) 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation thereof and pharmaceutical compositions containing them